INS and obesity disorder: The percentage of systemic palmitate coming from splanchnic palmitate release increased with each increment in insulin concentrations in the lean volunteers (all P < 0.02), but the increase was only statistically significant with the high insulin dose for the volunteers with obesity (P < 0.05 vs. both baseline and low-dose insulin).